A 50 by 7 data matrix of a contingency table from the FDA Adverse
Event Reporting System (FAERS) database, covering Q3 2014 to Q4 2020.
The 49 rows represent important adverse events associated with statins,
with the final row aggregating the remaining 5,990 events. The 49 AEs are
classified into three clusters (see statin49_AE_idx
for cluster indices):
1) AEs associated with muscle injury signs and symptoms, 2) AEs associated
with muscle injury lab tests, and 3) AEs associated with kidney injury and
its diagnosis and treatment.
The 7 columns include six statin medications and an "other drugs" column.
Marginal totals for each drug: 197,390 for Atorvastatin,
5,742 for Fluvastatin, 3,230 for Lovastatin, 22,486 for
Pravastatin, 122,450 for Rosuvastatin, 85,445 for Simvastatin, and
63,539,867 for Other drugs.